Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Calciphylaxis.

Sagar U Nigwekar¹

¹Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

Current Opinion in Nephrology and Hypertension

|April 5, 2017

Summary

This summary is machine-generated.

Calciphylaxis, a vascular disorder common in end-stage renal disease (ESRD) patients, has an incidence of 3.5 cases per 1000 patient-years. Vitamin K deficiency is a likely cause, and patient outcomes remain poor.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Calciphylaxis complicated by NDM-1-producing Pseudomonas aeruginosa: first experience with cefepime-zidebactam alongside phage therapy in the USA.

The Lancet. Infectious diseases·2026

Same author

Wound Management and Surgery for Calcific Uremic Arteriolopathy (Calciphylaxis): A Retrospective Observational Cohort Study.

International wound journal·2026

Same author

Risk Factors for Fatigue in Adults Receiving Maintenance Hemodialysis Who Have Chronic Pain: A Secondary Analysis of the HOPE Consortium Trial.

Kidney medicine·2026

Same author

Nephrotic syndrome genomic discovery in the Mass General Brigham Biobank identifies monoallelic MEFV variants as a risk factor for focal segmental glomerulosclerosis.

Kidney international·2025

Same author

Approach to Quality Control Used for the HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis.

Clinical journal of the American Society of Nephrology : CJASN·2025

Same author

Skin Disorders in Kidney Disease: Core Curriculum 2026.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2025

Same journal

Sex differences in renal acid-base regulation.

Current opinion in nephrology and hypertension·2026

Same journal

Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors.

Current opinion in nephrology and hypertension·2026

Same journal

Financial and policy challenges of delivering kidney replacement therapies in resource-limited settings.

Current opinion in nephrology and hypertension·2026

Same journal

The role of kir4.1/Kir5.1 in mediating the effect of angiotensin-II on Na-Cl-cotransporter.

Current opinion in nephrology and hypertension·2026

Same journal

Role of the calcium-sensing receptor in regulating calcium transport in the thick ascending limb.

Current opinion in nephrology and hypertension·2026

Same journal

Social determinants of chronic kidney disease: from association to clinical and population action.

Current opinion in nephrology and hypertension·2026

See all related articles

Area of Science:

Nephrology
Vascular Biology
Dermatology

Background:

Calciphylaxis is a rare but severe vascular calcification disorder.
It disproportionately affects patients with end-stage renal disease (ESRD).
Understanding its incidence, risk factors, and outcomes is crucial for patient care.

Purpose of the Study:

To review recent literature on calciphylaxis.
To highlight new data on incidence, risk factors, and outcomes.
To emphasize the role of emerging research in understanding pathogenesis.

Main Methods:

Review of recent literature and patient registry data.
Analysis of epidemiological data on calciphylaxis incidence.
Identification of risk factors and pathogenic mechanisms.

Related Experiment Videos

Main Results:

Estimated incidence of 3.5 new cases/1000 patient-years in ESRD patients on hemodialysis.
Potential for higher incidence in peritoneal dialysis patients.
Vitamin K deficiency and impaired Matrix Gla Protein carboxylation implicated in pathogenesis.
High mortality rates: 30% at 6 months, 50% at 12 months.

Conclusions:

Calciphylaxis remains a significant challenge in ESRD patients.
Further research, including registries and biorepositories, is essential.
This research will facilitate clinical trials and improve understanding of calciphylaxis.